Drug reference

oxyphenonium

Semisynthetic anticholinergic, Quaternary compound · Antispasmodic, Antisecretory

Semisynthetic anticholinergic, Quaternary compoundAntispasmodic, Antisecretory

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Oxyphenonium is a semisynthetic anticholinergic compound similar to propantheline, indicated for conditions involving peptic ulcer and gastrointestinal hypermotility.

Indications

Peptic ulcerGastrointestinal hypermotility

Dosing

Adult: 5–10 mg oral
Pediatric: 3–5 mg oral

Related guidelines

Gastric premalignant conditions

ACG · Gastroenterology · 2025

Preventive care in inflammatory bowel disease

ACG · Gastroenterology · 2025

Helicobacter pylori infection

ICMR · Gastroenterology · 2021

Inflammatory bowel disease

OTHER · Gastroenterology · 2015

Other Semisynthetic anticholinergic, Quaternary compound drugs

atropine methonitrate

pipenzolate methyl bromide

0 brands

propantheline

0 brands

Ask House about oxyphenonium

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team